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Introduction
According to the World Health Organization (WHO), stroke and
other cerebrovascular diseases are the second leading cause of death
worldwide [1]. Sequelae include partial paralysis, difficulties with
memory, thinking, language, and movements. The most common
cause of stroke is the sudden occlusion of a blood vessel by a thrombus
or embolus, resulting in an almost immediate loss of oxygen and
glucose to the cerebral tissue. It is well known that the inflammatory
process has an impact on post-ischemic tissue damage in the brain
[2,3-7]. Inflammation is an extremely important and complex
biological process of the immune system activated in response to
harmful stimuli such as pathogens and cell damage. In the last years
many efforts have been made to find useful diagnostic markers to be
used as disease monitor in patients after stroke. The ideal marker
should be involved in the the post-stroke events which include the
removal of pathogens and damaged cells and/or the healing process. In
particular, neutrophil/granulocyte [8,9] and macrophage/microglia
[10,11] have been identified as the principal actors in post-ischemic
processes.
Recent studies have shown that T-cells also have an impact on tissue
damage [12-20]. Several studies have seen that an attenuation of the
inflammatory process could be a possible way to widen the therapeutic
window after the acute event [8,11,12]. However, other studies pointed
out that the inflammatory response is necessary in order, for example,
to remove dead neurons and other brain cells in the ischaemic core,
and promote astrocytosis. Consequently, it is not possible to strictly
categorize the inflammatory process as being either beneficial or
deleterious in relation to stroke [13]. A few recent clinical studies
looked at the post-stroke inflammatory responses within the brain
[14,15].
High fibrinogen plasma levels are considered as an independent
predictor of myocardial infarction and ischemic stroke [16-18],
furthermore Potpara and colleagues identified the association of
plasma high fibrinogen levels with poor functional 30-day outcome in
ischemic stroke [19].
Our recent experience in inflammatory biomarker and stroke
rehabilitation demonstrated a fundamental role of fibrinogen
plasmatic levels on patient admission to the stroke rehabilitative care
and its correlation with gain in activities of daily living (ADL) at on
discharge from rehabilitative care.
In particular, we analysed the correlation with effectiveness of the
Functional Independence Measure (eFIM) scale and the plasmatic
levels of fibrinogen. The FIM is a basic indicator of severity of disability
for evaluating ADL in subjects with stroke. Total scores range from 18
to 126 and indicate to what extent an individual is capable to reach
independence in ADL. In our study we used the FIM effectiveness,
calculated as (FIM at discharge–FIM on admission)/(126–FIM on
admission) according to Koh and colleagues [20]. FIM effectiveness,
which is independent from FIM on admission, has been used to
compare patients with various degrees of disability severity. Another
indicator used to predict and to measure the cost of the rehabilitative
treatment is the rehabilitative Length of Stay (rLOS). The rLOS value
represents the total number of rehabilitation days from admission to
discharge.
From September 2015 to May 2016 we enrolled and analysed data
from 33 patients at their first ischemic stroke on admission to our
Rehabilitation Hospital. Their diagnoses of ischemic stroke were
confirmed with CT scan and/or MRI brain scans. All subjects enrolled
in the study underwent a multi-disciplinary rehabilitative approach
and high intensity therapy. In particular, all underwent routine
inpatient rehabilitation, consisting of a daily 3-hours physiotherapy
session, including both dexterity and gait training, according to
individually tailored exercise schedule.
Using the Pearson test we found a statistical correlation between
eFIM and fibrinogen level with r=0.4147 and a p=0.0096 and between
LOS and fibrinogen levels with r=0.5282 and a p=0.005. So far our
results showed that post-stroke fibrinogen level is significantly
associated with ADL functions and hospital costs in post-acute
ischemic stroke.
The extent of this analysis to other inflammatory markers in stroke
patients on admission to the rehabilitation unit could be an important
low cost and reproducible study looking at factors influencing rLOS as
well as useful tool to improve rehabilitation resources planning for
stroke patients from early days. Fibrinogen could be candidate as a
significant predictor of the rLOS in patients with ischemic stroke as it
is simple to measure, inexpensive, available biomarker and may be
used as a practical tool to guide the economic burden of stroke. On
that basis in the future, however, additional studies are required to
confirm our results.
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